OSR1 and steatosis: Previous findings from our lab have explored the role of Osr1 to inhibit hepatic injury caused by HFD and DEN, potentially serving to depress its progression to HCC.(20) We report in this pre-cancer model that Osr1 heterozygote mice exhibited more steatosis.